Alkemi Venture Partners

Alkemi Venture Partners is a venture capital firm based in New Delhi, India, focusing on early-stage investments across a diverse range of sectors. Their mission is to elevate the health and well-being of the Indian consumer while maximizing returns to their shareholders. They support entrepreneurs who are visionary, bold, and resilient, aiming to make a significant impact in the Indian healthcare industry.

The firm manages two funds: Alkemi Venture Fund I and Alkemi Venture Fund II - Scheme I, both registered with the Securities and Exchange Board of India (SEBI). Alkemi Venture Fund II - Scheme I has a corpus of ₹1,140 crore, with a capital commitment of ₹150 crore from the SRI Fund. The fund manager is Alkemi Growth Capital LLP.

Alkemi Venture Partners has made 20 investments, with their most recent investment on February 26, 2025, in Quick Clean Pvt. Ltd. They have had at least one exit, with Doxper being a notable example. Their portfolio includes companies across various industries, reflecting their broad investment approach.

The firm's advisory board comprises leading professionals such as Shantanu Mukerji, MD of Gulf Capital; Rohit Kapoor, CEO of Swiggy; Priyanka Aggarwal, MD of BCG; Pankaj Sahni, CEO of Medanta; Utsav Baijal, Head of India PE at Apollo Management; Aditya Ghosh, Co-founder of Akasa Air; and Abhishek Kalra, Ex-MD of Lehman Brothers.

Alkemi Venture Partners is committed to supporting entrepreneurs who are inspired by a vision, possess boldness, and are not afraid to face challenges. They focus on building companies that can make an outsized difference in the Indian healthcare industry, aiming to elevate the health and well-being of the Indian consumer while maximizing returns to their shareholders.